RESUMEN
Isolates of Alternaria dauci causing Alternaria leaf blight (ALB) were collected from commercial carrot (Daucus carota var. sativus) fields in northeastern North America during 2004. Twenty-two isolates representing a range of genetic diversity were analyzed for their aggressiveness on three commercial carrot varieties (Bolero, Enterprise, and Heritage) varying in disease susceptibility as well as their in vitro response to three fungicides (azoxystrobin, chlorothalonil, and boscalid) commonly used for ALB control. Severity of leaf and petiole blight and leaf chlorosis varied among isolates and carrot varieties in each of three experiments. Visible differences in disease severity, which ranged from 10.9 to 45.1% of the leaf area affected, were apparent 16 days after inoculation. Intensity of chlorosis correlated strongly with blight severity among all isolates. Significant differences were noted among carrot varieties in response to ALB. These varieties may prove useful as differentials capable of distinguishing isolates because variety by isolate interactions were detected. Inhibition of conidial germination ranged from 0.01 to 0.37 µg/ml for azoxystrobin, 0.009 to 0.08 µg/ml for chlorothalonil, and 0.09 to 0.59 µg/ml for boscalid. On average, isolates were more sensitive to chlorothalonil than to azoxystrobin and boscalid. No significant correlation was noted between fungicide sensitivity and aggressiveness. These data provide evidence for phenotypic diversity among A. dauci isolates collected from areas of commercial carrot production.
RESUMEN
OBJECTIVE: Understanding the regulation of adipocyte differentiation by cellular and extracellular factors is crucial for better management of chronic conditions such as obesity, insulin resistance and lipodystrophy. Experimental infection of rats with a human adenovirus type 36 (Ad-36) improves insulin sensitivity and promotes adipogenesis, reminiscent of the effect of thiozolinediones. Therefore, we investigated the role of Ad-36 as a novel regulator of the adipogenic process. DESIGN AND RESULTS: Even in the absence of adipogenic inducers, infection of 3T3-L1 preadipocytes and human adipose-derived stem cells (hASC) by Ad-36, but not Ad-2 that is another human adenovirus, modulated regulatory points that spanned the entire adipogenic cascade ranging from the upregulation of cAMP, phosphatidylinositol 3-kinase and p38 signaling pathways, downregulation of Wnt10b expression, and increased expression of CCAAT/enhancer binding protein-beta and peroxisome proliferator-activated receptor gamma2 and consequential lipid accumulation. Next, we identified that E4 open reading frame (orf)-1 gene of the virus is necessary and sufficient for Ad-36-induced adipogenesis. Selective knockdown of E4 orf-1 by RNAi abrogated Ad-36-induced adipogenic signaling cascade in 3T3-L1 cells and hASC. Compared to the null vector, selective expression of Ad-36 E4 orf-1 in 3T3-L1 induced adipogenesis, which was abrogated when the PDZ-binding domain of the protein was deleted. CONCLUSION: Thus, Ad-36 E4 orf-1 is a novel inducer of rodent and human adipocyte differentiation process.
Asunto(s)
Adenovirus Humanos/genética , Adipocitos/citología , Adipogénesis/genética , Diferenciación Celular , Proteínas Oncogénicas Virales/genética , Células 3T3-L1 , Animales , Humanos , Ratones , Proteínas Oncogénicas Virales/fisiología , RatasRESUMEN
Fixed sample-size plans for monitoring Plutella xylostella (L.) (Lepidoptera: Plutellidae) on broccoli and other Brassica vegetable crops are popular in Australia for their simplicity and ease of application. But the sample sizes used are often small, approximately 10-25 plants per crop, and it may be that they fail to provide sufficient information upon which to base pest control decisions. We tested the performance of seven fixed sample-size plans (10, 15, 20, 30, 35, 40, and 45 plants) by resampling a large data set on P. xylostella in commercial broccoli crops. For each sample size, enumerative and presence-absence plans were assessed. The precision of the plans was assessed in terms of the ratio of the standard error to the mean; and at least 45 and 35 samples were necessary for the enumerative and presence-absence plans, respectively, to attain the generally accepted benchmark of < or = 0.3. Sample sizes of 10-20 were highly imprecise. We also assessed the consequences of classifications based on action thresholds (ATs) of 0.2 and 0.8 larvae per plant for the enumerative case, and 0.15 and 0.45 proportion of plants of infested for the presence-absence case. Operating characteristic curves and investigations of the frequency of correct decisions suggest improvements in the performance of plans with increased sample size. In both the enumerative and presence-absence cases, the proportion of incorrect decisions was much higher for the lower of the two ATs assessed, and type II errors (i.e., failure to suggest pest control upon the AT is exceeded) generally accounted for the majority of this error. Type II errors are the most significant from a producer's standpoint. Further consideration is necessary to determine what is an acceptable type II error rate.
Asunto(s)
Brassica , Control de Insectos/métodos , Mariposas Nocturnas , Tamaño de la Muestra , Animales , Australia , Proyectos de InvestigaciónRESUMEN
Foliar diseases of carrot caused by Alternaria dauci and Cercospora carotae occur every year in Wisconsin, requiring repeated foliar fungicide applications to minimize defoliation and yield reduction. Improved timing of fungicide applications combined with the use of disease resistant cultivars offer growers a means to improve disease control with fewer fungicide inputs compared with the current strategy of weekly fungicide applications to a susceptible cultivar. Field experiments in 2002 to 2004 examined fungicide application schedules indicated by a disease forecasting model that calculated the duration of environmental conditions favorable for A. dauci and C. carotae (adaptation of TOM-CAST) on two carrot cultivars differing in susceptibility to these foliar diseases. All fungicide programs were initiated at a 1% disease severity threshold determined by scouting. Intervals for weather-based spray programs were based on in-canopy leaf wetness and temperature data. Fungicide sprays were applied according to 15 and 20 disease severity value (DSV) application thresholds, and were compared with a weekly spray program and an untreated control. Results of this trial demonstrated that fungicide sprays made according to weather data may reduce fungicide inputs in most years compared with current industry-standard, calendar-based spray programs. Host susceptibility affected the efficacy of weather-based spray programs, resulting in longer spray intervals and fewer fungicide applications on the resistant cultivar Bolero when compared with the susceptible cultivar Fontana. Fungicide spray programs based on TOM-CAST diminished fungicide inputs by 30 to 50%, compared with the weekly spray program, by lengthening intervals between applications without compromising disease control or root yield.
RESUMEN
With recent advances in dental technology, titanium is currently used for fabrication of crowns, fixed partial dentures, implant frameworks, and removable partial denture frameworks. The use of titanium-aluminum-vanadium (Ti-6Al-4V) alloy assumes that it imparts similar anti-corrosion characteristics to the commercially pure titanium. This clinical report describes a patient who experienced discoloration of a Ti-6Al-4V alloy removable partial denture.
Asunto(s)
Aleaciones Dentales/química , Dentadura Parcial Removible , Titanio/química , Aleaciones , Color , Corrosión , Pulido Dental , Limpiadores de Dentadura , Diseño de Dentadura , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Propiedades de Superficie , Cepillado DentalRESUMEN
N-Acetyl-4-S-cysteaminylphenol 1 is an analogue of a biosynthetic intermediate in the pathway to melanin. It is probably oxidized to an o-quinone which can alkylate cellular nucleophiles resulting in interference with cell growth and proliferation. It is reported to have useful anti-melanoma activity. We previously synthesized a range of analogues of 1 by varying the acyl portion of the amide. A modest increase in melanoma activity against six melanoma cell lines for these analogues could be correlated with increased lipophilicity. Thirteen new analogues of 1 containing two methyl groups at the alpha-position of the amino component and various acyl groups have now been prepared and assessed for anti-melanoma activity against six human melanoma cell lines. Most of the new compounds displayed greater cytotoxicity than the lead compound 1. The highest cytotoxicity against the cell lines was observed for the cyclohexylacetamide 11 followed by the cyclohexylcarboxamide 10 and the 2,2-dimethylpropanamide 6. The IC50 values of the most cytotoxic compound 11 against the cell lines were comparable with those of cisplatin. Small variations in the acyl components of these analogues, such as reducing the ring size, lengthening the carbon chain and reducing the amount of chain branching, resulted in a considerable loss of cytotoxicity. The moderate activity of 6, 10 and 11 against SK-Mel-24 cells (non-tyrosinase containing) and an ovarian cell line suggests that interference with the melanin pathway may not be their only mode of action.
Asunto(s)
Antineoplásicos/síntesis química , Antineoplásicos/farmacología , Cisteamina/análogos & derivados , Cisteamina/síntesis química , Cisteamina/farmacología , Melanoma Experimental/tratamiento farmacológico , Fenoles/síntesis química , Fenoles/farmacología , Ensayos de Selección de Medicamentos Antitumorales , Femenino , Humanos , Indicadores y Reactivos , Neoplasias Ováricas/tratamiento farmacológico , Relación Estructura-Actividad , Células Tumorales CultivadasRESUMEN
N-Acetyl-4-S-cysteaminylphenol (1) has been shown by Jimbow and co-workers to possess useful antimelanoma activity. It is an analogue of a biosynthetic intermediate in the pathway to melanin and probably acts as a prodrug, being oxidized to an o-quinone which reacts with essential enzymes containing sulphydryl groups resulting in interference with cell growth and proliferation. We have synthesized a range of analogues of 1 by varying the acyl portion of the amide with the intention of increasing the lipophilicity of the compounds. A modest increase in melanoma activity against six melanoma cell lines for these analogues could be correlated with increased lipophilicity. The most active of these compounds, N-[2-[(4-hydroxyphenyl)thiol]ethyl]cyclohexanecarboxamide (9), showed promising selectivity (lack of cytotoxicity) on the non-melanotic cell line SK-Mel-24 and on an ovarian cell line. A significant improvement in antimelanoma activity was observed with a new type of analogue containing three carbon atoms between the sulphur and nitrogen. The most active of these new analogues, N-[3-[(4-hydroxyphenyl)-thiolpropyl]-1-cyclohexanecarboxamide (15), had activity comparable to cisplatin against several cell lines and low cytotoxicity towards the non-melanotic cell line.
Asunto(s)
Antineoplásicos/síntesis química , Antineoplásicos/farmacología , Cisteamina/análogos & derivados , Cisteamina/síntesis química , Cisteamina/farmacología , Melanoma/tratamiento farmacológico , Fenoles/síntesis química , Fenoles/farmacología , División Celular/efectos de los fármacos , Inhibidores de Crecimiento/síntesis química , Inhibidores de Crecimiento/farmacología , Humanos , Melanoma/patología , Relación Estructura-Actividad , Células Tumorales Cultivadas/efectos de los fármacosRESUMEN
BACKGROUND: To our knowledge, 17-allylamino,17-demethoxygeldanamycin (17AAG) is the first inhibitor of heat shock protein 90 (Hsp90) to enter a phase I clinical trial in cancer. Inhibition of Hsp90, a chaperone protein (a protein that helps other proteins avoid misfolding pathways that produce inactive or aggregated states), leads to depletion of important oncogenic proteins, including Raf-1 and mutant p53 (also known as TP53). Given its ansamycin benzoquinone structure, we questioned whether the antitumor activity of 17AAG was affected by expression of the NQO1 gene, which encodes the quinone-metabolizing enzyme DT-diaphorase. METHODS: The antitumor activity of 17AAG and other Hsp90 inhibitors was determined by use of a sulforhodamine B-based cell growth inhibition assay in culture and by the arrest of xenograft tumor growth in nude mice. DT-diaphorase activity was determined by use of a spectrophotometric assay, and protein expression was determined by means of western immunoblotting. RESULTS: In two independent in vitro human tumor cell panels, we observed a positive relationship between DT-diaphorase expression level and growth inhibition by 17AAG. Stable, high-level expression of the active NQO1 gene transfected into the DT-diaphorase-deficient (by NQO1 mutation) BE human colon carcinoma cell line resulted in a 32-fold increase in 17AAG growth-inhibition activity. Increased sensitivity to 17AAG in the transfected cell line was also confirmed in xenografts. The extent of depletion of Raf-1 and mutant p53 protein confirmed that the Hsp90 inhibition mechanism was maintained in cells with high and low levels of DT-diaphorase. 17AAG was shown to be a substrate for purified human DT-diaphorase. CONCLUSION: These results suggest that the antitumor activity and possibly the toxicologic properties of 17AAG in humans may be influenced by the expression of DT-diaphorase. Careful monitoring for NQO1 polymorphism and the level of tumor DT-diaphorase activity is therefore recommended in clinical trials with 17AAG.
Asunto(s)
Antibióticos Antineoplásicos/farmacología , Neoplasias del Colon/tratamiento farmacológico , Neoplasias del Colon/enzimología , Dihidrolipoamida Deshidrogenasa/metabolismo , Inhibidores Enzimáticos/farmacología , Proteínas HSP90 de Choque Térmico/antagonistas & inhibidores , Neoplasias Ováricas/tratamiento farmacológico , Neoplasias Ováricas/enzimología , Rifabutina/análogos & derivados , Benzoquinonas , Femenino , Regulación Enzimológica de la Expresión Génica , Regulación Neoplásica de la Expresión Génica , Humanos , Lactamas Macrocíclicas , Lactonas/farmacología , Macrólidos , Quinonas/farmacología , Rifabutina/farmacología , Células Tumorales CultivadasRESUMEN
OBJECTIVE: To illustrate the use of percutaneous ultrasound-guided biopsy of the gastrointestinal tract in HIV-infected patients to obtain a tissue diagnosis. DESIGN: The technique was used in relation to relevant clinical situations in which a diagnosis may have only been reached by open biopsy. METHOD: Three HIV-infected patients with suspected gastrointestinal tract lesions underwent percutaneous ultrasound-guided biopsy under local anaesthetic. RESULTS: A tissue diagnosis was made in each case resulting in initiation or continuation of appropriate therapy and avoided the need for open biopsy under general anaesthetic. CONCLUSION: Although the number of patients undergoing the procedure in this series was small, the technique has so far been shown to be safe and effective with few complications.
Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/diagnóstico , Biopsia con Aguja/métodos , Sistema Digestivo/patología , Linfoma de Células B/diagnóstico , Linfoma de Células T/diagnóstico , Tuberculosis Gastrointestinal/diagnóstico , Infecciones Oportunistas Relacionadas con el SIDA/diagnóstico por imagen , Infecciones Oportunistas Relacionadas con el SIDA/virología , Adulto , Sistema Digestivo/diagnóstico por imagen , Infecciones por VIH/complicaciones , Humanos , Linfoma de Células B/diagnóstico por imagen , Linfoma de Células B/virología , Linfoma de Células T/diagnóstico por imagen , Linfoma de Células T/virología , Masculino , Persona de Mediana Edad , Tuberculosis Gastrointestinal/diagnóstico por imagen , Tuberculosis Gastrointestinal/virología , UltrasonografíaRESUMEN
The 3rd annual European Plasma Fractionators Association/National Institut of Biological Standard and Control (EPFA/NIBSC) meeting provided a forum for regulators, blood product and test kit manufacturers and organisations developing standards to present and discuss their latest data. The main conclusions were as follows. There has been substantial progress during the last year in the development of NAT technology specifically for improving the safety of blood products though there is an urgent need for the development of international reference materials. The technology is not yet sufficiently developed to be used as a routine screening test though testing of plasma pools for hepatitis C virus may be achieved within a year. Introduction of testing should not result in the creation of dual standards for plasma derived and cellular products. Once the technology is fully developed it could significantly improve the safety of all blood products, particularly those derived from starting materials with a high incidence of viral markers.
Asunto(s)
ADN Viral/sangre , Amplificación de Genes , Tamizaje Masivo/métodos , ARN Viral/sangre , Viremia/diagnóstico , Sangre/virología , Donantes de Sangre , Unión Europea , Alemania , Humanos , Incidencia , Control de Infecciones , Tamizaje Masivo/legislación & jurisprudencia , Técnicas de Amplificación de Ácido Nucleico , Reacción en Cadena de la Polimerasa , Prevalencia , Juego de Reactivos para Diagnóstico , Sensibilidad y Especificidad , Estados Unidos , Viremia/epidemiologíaRESUMEN
The mechanisms by which cis-diamminedichloroplatinum(II) (cisplatin) is transported across the plasma membrane (i.e., passive diffusion versus active transport) were investigated in the 41M and CH1 human ovarian carcinoma cell lines and their acquired cisplatin-resistant variants 41McisR6 and CH1cisR6, respectively. Intracellular cisplatin accumulation was significantly reduced (4.0 +/- 1.7-fold) in the parental 41M line at 4 degrees C when compared to incubations at 37 degrees C. However, no significant differences in platinum uptake were observed in the 41McisR6 and in the CH1 pair of lines at 4 degrees C versus 37 degrees C. Similarly, in the presence of ouabain (an inhibitor of Na+,K+-ATPase), there was a marked reduction (2.0 +/- 0.4-fold) in drug accumulation in the sensitive 41M cells only, and no changes in drug uptake were observed in the other cell lines in the absence or presence of ouabain. Platinum accumulation was significantly enhanced in all cell lines in the presence of metabolic inhibitors (NaF and NaN3). These results suggest that in the parental 41M cell line, cisplatin transport may occur via passive diffusion and active/facilitated transport, whereas in the resistant 41McisR6 variant, cisplatin enters cells by passive diffusion only. The orally active drug bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV) (JM216) is a lipophilic platinum(IV) complex that has been shown to circumvent cisplatin resistance in the 41McisR6 by increasing drug uptake. Across the entire range of concentrations used (5-50 microm), intracellular accumulation of JM216 was significantly reduced in 41M and 41McisR6 cells (3.5 +/- 0.7-fold; P < 0.01), and in CH1 and CH1cisR6 cells (14.2 +/- 6.0-fold; p < 0.01) at 4 degrees C when compared to incubations at 37 degrees C. No significant difference in JM216 uptake was observed in the 41M pair of lines in the absence or presence of ouabain. Additional studies have revealed that the fold reduction observed in cis-ammine(cyclohexylamine)dichloroplatinum(II) (JM118) accumulation in the 41M and 41McisR6 cells at 4 degrees C (3.7 +/- 1.9) reflects similar fold reductions to those observed with JM216 uptake at 4 degrees C. These results suggest that the mechanism of JM216 transport across cell membranes is through passive diffusion, predominantly as a result of its enhanced lipophilicity. Notably, an overexpression of a Mr 36,000 plasma membrane protein was observed in the 41McisR variants when compared to the sensitive 41M line. Increased levels of this Mr 36,000 protein may relate to the observed reduction in active transport of cisplatin in the 41McisR6 variant. Tyrosine phosphorylation of the Mr 36,000 protein appeared to be greater in the resistant 41McisR6 variant than in the parental 41M line. In addition, the constitutive levels of the Mr 36,000 protein in the CH1 pair of lines and in two acquired JM216-resistant variants (41M/JM216R and CH1/JM216R), where resistance in these cell lines is not mediated through reduced drug uptake, were similar to those observed in their respective parental lines. These results suggest that the overexpression of this Mr 36,000 protein in the acquired cisplatin-resistant subline 41McisR6 may play a significant role in cisplatin uptake in resistant cells exhibiting reduced drug accumulation as a major mechanism of cisplatin resistance.
Asunto(s)
Antineoplásicos/farmacocinética , Cisplatino/farmacocinética , Compuestos Organoplatinos/farmacocinética , Membrana Celular/metabolismo , Resistencia a Antineoplásicos , Inhibidores Enzimáticos/farmacología , Femenino , Humanos , Ouabaína/farmacología , Neoplasias Ováricas/metabolismo , Platino (Metal)/metabolismo , Temperatura , Células Tumorales Cultivadas/metabolismoAsunto(s)
Trastornos de la Menstruación/diagnóstico por imagen , Neumotórax/diagnóstico por imagen , Adulto , Anticonceptivos Orales/administración & dosificación , Anticonceptivos Orales/uso terapéutico , Combinación de Medicamentos , Femenino , Humanos , Hidroneumotórax/diagnóstico por imagen , Laparoscopía , Pulmón/diagnóstico por imagen , Trastornos de la Menstruación/tratamiento farmacológico , Mestranol/uso terapéutico , Óxido Nitroso , Noretinodrel/uso terapéutico , Neumoperitoneo Artificial , Neumotórax/tratamiento farmacológico , Neumotórax/etiología , Tomografía por Rayos X , Hemorragia Uterina/prevención & controlRESUMEN
Uninoculated roots of pea (Pisum sativum) and French bean (Phaseolus vulgaris) have been shown to exude a number of antifungal compounds when grown in a non-sterile aqueous aerated medium. These have been identified and their possible importance in relation to disease resistance is discussed.